Avinash V. Dharmadhikari,Rajarshi Ghosh,Bo Yuan,Pengfei Liu,Hongzheng Dai,Sami Al Masri,Jennifer Scull,Jennifer E. Posey,Allen H. Jiang,Weimin He,Francesco Vetrini,Alicia A. Braxton,Patricia Ward,Theodore Chiang,Chunjing Qu,Shen Gu,Chad A. Shaw,Janice L. Smith,Seema Lalani,Pawel Stankiewicz,Sau-Wai Cheung,Carlos A. Bacino,Ankita Patel,Amy M. Breman,Xia Wang,Linyan Meng,Rui Xiao,Fan Xia,Donna Muzny,Richard A. Gibbs,Arthur L. Beaudet,Christine M. Eng,James R. Lupski,Yaping Yang,Weimin Bi

Abstract:Background Exome sequencing (ES) has been successfully applied in clinical detection of single nucleotide variants (SNVs) and small indels. However, identification of copy number variants (CNVs) using ES data remains challenging. The purpose of this study is to understand the contribution of CNVs and copy neutral runs of homozygosity (ROH) in molecular diagnosis of patients referred for ES. Methods In a cohort of 11,020 consecutive ES patients, an Illumina SNP array analysis interrogating mostly coding SNPs was performed as a quality control (QC) measurement and for CNV/ROH detection. Among these patients, clinical chromosomal microarray analysis (CMA) was performed at Baylor Genetics (BG) on 3229 patients, either before, concurrently, or after ES. We retrospectively analyzed the findings from CMA and the QC array. Results The QC array can detect ~ 70% of pathogenic/likely pathogenic CNVs (PCNVs) detectable by CMA. Out of the 11,020 ES cases, the QC array identified PCNVs in 327 patients and uniparental disomy (UPD) disorder-related ROH in 10 patients. The overall PCNV/UPD detection rate was 5.9% in the 3229 ES patients who also had CMA at BG; PCNV/UPD detection rate was higher in concurrent ES and CMA than in ES with prior CMA (7.2% vs 4.6%). The PCNVs/UPD contributed to the molecular diagnoses in 17.4% (189/1089) of molecularly diagnosed ES cases with CMA and were estimated to contribute in 10.6% of all molecularly diagnosed ES cases. Dual diagnoses with both PCNVs and SNVs were detected in 38 patients. PCNVs affecting single recessive disorder genes in a compound heterozygous state with SNVs were detected in 4 patients, and homozygous deletions (mostly exonic deletions) were detected in 17 patients. A higher PCNV detection rate was observed for patients with syndromic phenotypes and/or cardiovascular abnormalities. Conclusions Our clinical genomics study demonstrates that detection of PCNV/UPD through the QC array or CMA increases ES diagnostic rate, provides more precise molecular diagnosis for dominant as well as recessive traits, and enables more complete genetic diagnoses in patients with dual or multiple molecular diagnoses. Concurrent ES and CMA using an array with exonic coverage for disease genes enables most effective detection of both CNVs and SNVs and therefore is recommended especially in time-sensitive clinical situations.

Structural variant calling and clinical interpretation in 6224 unsolved rare disease exomes

Full characterization of unresolved structural variation through long-read sequencing and optical genome mapping

Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases

Integration of transcriptomics and long-read genomics prioritizes structural variants in rare disease

Mapping structural variants to rare disease genes using long-read whole genome sequencing and trait-relevant polygenic scores

Uncovering recessive alleles in rare Mendelian disorders by genome sequencing of 174 individuals with monoallelic pathogenic variants

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

A comparative study of structural variant calling in WGS from Alzheimers disease families

Mapping and characterization of structural variation in 17,795 deeply sequenced human genomes

Unravelling undiagnosed rare disease cases by HiFi long-read genome sequencing

Hidden Biases in Germline Structural Variant Detection.

A novel approach for simultaneous detection of structural and single-nucleotide variants based on a combination of chromosome conformation capture and exome sequencing

Multi-platform Discovery of Haplotype-Resolved Structural Variation in Human Genomes

Exome copy number variant detection, analysis, and classification in a large cohort of families with undiagnosed rare genetic disease

Copy Number Variant and Runs of Homozygosity Detection by Microarrays Enabled More Precise Molecular Diagnoses in 11,020 Clinical Exome Cases

Structural variant analysis of a cancer reference cell line sample using multiple sequencing technologies

Structural variation and fusion detection using targeted sequencing data from circulating cell free DNA

A High-Quality Human Reference Panel Reveals the Complexity and Distribution of Genomic Structural Variants

Long-read sequencing and structural variant characterization in 1,019 samples from the 1000 Genomes Project

Combining optical genome mapping and RNA-seq for structural variants detection and interpretation in unsolved neurodevelopmental disorders

Assessing structural variation in a personal genome—towards a human reference diploid genome